Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18

Benzinga Newsdesk www.benzinga.com Positive 60.7%

Neg 0% Neu 0% Pos 60.7%

Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.